tofersen

Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
BioSpace
Thu, 04/27/23 - 11:51 am
Biogen
Qalsody
tofersen
ALS
drug development
R&D
FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS
Medical Marketing and Media
Tue, 04/25/23 - 10:20 pm
Biogen
Ionis Pharmaceuticals
ALS
tofersen
FDA
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biogen
tofersen
ALS
Seres Therapeutics
C. difficile
Pfizer
GSK
vaccines
RSV
Regeneron
Eylea
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
Investors Business Daily
Thu, 03/23/23 - 09:58 am
Ionis Pharmaceuticals
Biogen
ALS
FDA
tofersen
FDA advisers support conditional clearance of Biogen’s ALS drug
BioPharma Dive
Wed, 03/22/23 - 09:23 pm
Biogen
ALS
FDA
tofersen
Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm
BioSpace
Mon, 03/20/23 - 11:40 am
ALS
Biogen
Ionis Pharmaceuticals
FDA
tofersen
clinical trials
Biogen/ Ionis ALS therapy set for March FDA AdCom meeting
Seeking Alpha
Mon, 01/23/23 - 11:12 am
Biogen
Ionis Pharmaceuticals
FDA
ALS
tofersen
Biogen's ALS Drug Tofersen Filing Accepted in Europe
Zacks.com
Tue, 12/6/22 - 10:48 am
Biogen
ALS
EMA
Europe
tofersen
Biogen's Q3 revenue declines 10% as focus shifts to new Alzheimer's and ALS drug candidates
Endpoints
Tue, 10/25/22 - 11:05 am
Biogen
earnings
Alzheimer's disease
ALS
tofersen
lecanemab
Biogen's ALS ambitions on pause as FDA delays approval decision by 3 months
Fierce Biotech
Mon, 10/17/22 - 10:53 am
Biogen
tofersen
FDA
ALS
Biogen bolsters case for ALS drug under FDA review with new published data
MedCity News
Fri, 09/23/22 - 10:36 am
Biogen
ALS
FDA
tofersen
FDA, in another test of its flexibility, agrees to review Biogen’s closely watched ALS drug
BioPharma Dive
Tue, 07/26/22 - 11:08 am
Biogen
ALS
tofersen
FDA
ANA 2021 – Ionis rocked by tofersen flop
EP Vantage
Mon, 10/18/21 - 10:58 am
Biogen
Ionis Pharmaceuticals
clinical trials
ALS
tofersen
Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD1-ALS
Yahoo Finance
Sun, 10/17/21 - 11:04 pm
Biogen
tofersen
clinical trials
ALS
Promised EAP Date Approaching for Biogen's Highly Publicized ALS Drug
BioSpace
Wed, 06/30/21 - 12:13 am
Biogen
tofersen
ALS
Following pressure, Biogen to start compassionate use program for ALS drug tofersen
Seeking Alpha
Tue, 04/27/21 - 10:58 am
Biogen
ALS
tofersen
compassionate use guidelines
Biogen Shares Positive Data on Phase I/II Trial of Tofersen for SOD1-ALS
BioSpace
Sat, 07/11/20 - 11:45 am
Biogen
ALS
tofersen
BIIB067
clinical trials
Biogen’s Experimental Drug Shows Promise for Genetic Form of ALS
BioSpace
Wed, 05/15/19 - 11:43 pm
Biogen
tofersen
antisense
Ionis Pharmaceuticals
ALS